These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 13898488)

  • 1. Treatment of hypertension with bretylium tosylate. A selective sympathetic inhibitor.
    GIFFORD RW; SCHIRGER A
    Am J Cardiol; 1962 Jun; 9():841-7. PubMed ID: 13898488
    [No Abstract]   [Full Text] [Related]  

  • 2. Bretylium tosylate in the treatment of hypertension.
    BAUER CE
    Jpn Circ J; 1961 May; 25():487-92. PubMed ID: 13865849
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of bretylium tosylate with guanethidine in the treatment of severe hypertension.
    EVANSON JM; SEARS HT
    Lancet; 1960 Aug; 2(7147):387-9. PubMed ID: 13821025
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience with bretylium tosylate.
    LEWIS JA
    Can Med Assoc J; 1960 Apr; 82(17):877-81. PubMed ID: 14416531
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypotensive action of bretylium tosylate (darenthin).
    HODGE JV; SMIRK FH
    Am Heart J; 1960 Oct; 60():539-44. PubMed ID: 13714830
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective inhibition of the sympathetic nervous system in man with bretylium tosylate, a new antihypertensive agent.
    FREIS ED; SUGIURA T; LIPTAK D
    Circulation; 1960 Aug; 22():191-7. PubMed ID: 13849851
    [No Abstract]   [Full Text] [Related]  

  • 7. Bretylium tosylate as an antihypertensive drug.
    HURLEY RE; PAGE IH; DUSTAN HP
    J Am Med Assoc; 1960 Apr; 172():2081-3. PubMed ID: 14405524
    [No Abstract]   [Full Text] [Related]  

  • 8. Bretylium tosylate: long-term clinical trial of new hypotensive agent.
    STUCKEY D
    Med J Aust; 1960 Jul; 47(2)():166-8. PubMed ID: 13835383
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of bretylium tosylate on renal function in the course of arterial hypertension].
    ZUCCHELLI P; DALMASTRI G
    G Clin Med; 1961 Jan; 42():1-14. PubMed ID: 13788864
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of intermittent bretylium tosylate (darenthin) on the development of vascular disease in rats with hypertension caused by sodium retention.
    GARDNER DL
    Br J Exp Pathol; 1962 Feb; 43(1):88-92. PubMed ID: 13896894
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of bretylium tosylate on blood-pressure, cardiac output, and renal function in hypertension.
    DOYLE AE; FRASER JR; SMITH PK
    Br Med J; 1960 Aug; 2(5196):422-5. PubMed ID: 13817928
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bretylium tosylate (Darenthin). Report of an experiment on the clinical significance of bretylium tosylate in the treatment of hypertension].
    ZELVELDER WG
    Ned Tijdschr Geneeskd; 1961 Jun; 105():1260-6. PubMed ID: 13788182
    [No Abstract]   [Full Text] [Related]  

  • 13. A sympathetic blocking agent, bretylium tosylate (Darenthin), in the treatment of hypertension.
    CONWAY J; LAUWERS P; HOOBLER SW
    J Lab Clin Med; 1961 Feb; 57():199-205. PubMed ID: 13695220
    [No Abstract]   [Full Text] [Related]  

  • 14. Sympathetic blockade in treatment of hypertension. Clinical trial of bretylium tosylate.
    LOWTHER CP; TURNER RW
    Br Med J; 1960 Oct; 2(5205):1049-53. PubMed ID: 13763868
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on a new hypotensive agent: bretylium tosylate.
    GENEST J; DUFAULT G; PIGEON G; DAVIGNON J; BIRON P; TRUDEL J
    Can Med Assoc J; 1960 Apr; 82(17):872-7. PubMed ID: 13827287
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and experimental studies on bretylium tosylate, a new hypotensive agent.
    HAYDEN JG; BOAKE WC
    Med J Aust; 1960 Apr; 47(1)():528-32. PubMed ID: 14400312
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of bretylium tosylate (Darenthin) on pulmonary circulation.
    HALMAGYI DF; COLEBATCH HJ
    Circ Res; 1961 Jan; 9():136-8. PubMed ID: 13710880
    [No Abstract]   [Full Text] [Related]  

  • 18. Sympathetic nerve blocking drugs for the treatment of hypertension. TM-10, beta TM-10, bretylium and guanethidine.
    AVIADO DM
    Am J Med Sci; 1961 May; 241():650-61. PubMed ID: 13685282
    [No Abstract]   [Full Text] [Related]  

  • 19. The circul atory effects of bretylium tosylate and guanethidine.
    TAYLOR SH; DONALD KW
    Lancet; 1960 Aug; 2(7147):389-94. PubMed ID: 13837199
    [No Abstract]   [Full Text] [Related]  

  • 20. Muscle weakness caused by bretylium tosylate.
    CAMPBELL ED; MONTUSCHI E
    Lancet; 1960 Oct; 2(7154):789. PubMed ID: 13690224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.